While the pandemic was often blamed for 2020-2021’s strong recreational cannabis sales growth, the boost in sales was more likely due to existing trends, added stores and new products.
Colorado, Washington, Alaska and Oregon all experienced big increases in both deposits and lending shortly after legalizing marijuana for recreational use.
Non-intoxicating cannabis products are safe and well tolerated by those who use them, so why not lower the clinical threshold for their manufacture and sale?
As many as 33 American states and several European countries are looking to legalize recreational cannabis. Canada’s experience has lessons for them about how best to sell cannabis.
Accidental ingestion of drugs can have detrimental effects on dogs’ health. Education and awareness can help protect pets from consuming opioids and cannabis products.
Mexico would not fully legalize cannabis; its new regulation plan makes recreational use legal. However modest, that would be a symbolic milestone for a country immersed in a long, deadly drug war.
Growing weed indoors is not an environmentally friendly process. Climate controls create a lot of greenhouse gas emissions, and where the pot is produced has a huge influence on emission levels.
If the goal of cannabis legalization was to protect public health and safety, education and awareness campaigns must normalize safe cannabis use, not stop cannabis consumption.
Weed, though far less dangerous than many other drugs, is not entirely without risk. Some 59% of people treating pain with medical cannabis experience moderate to severe withdrawal symptoms
Health Canada should revise its cannabis regulations to let producers differentiate themselves from competitors and explain their products to consumers.
A cannabis decriminalization bill approved by the House is a sign from Congress that sentiment around the drug is evolving, but it misses a chance to regulate marijuana for the good of all Americans.